NFKB1 and breast cancer: Considering the fact that there are different ways to activate NF-kB pathway (IkB dependent and independent ways) [46] we decided to inhibit IKK activity rather than targeting IkappaBalpha itself to look for the possibility of sensitizing MCF7 breast cancer cells to TRAIL.